BACKGROUND: We assessed the compliance with self-collection of stool smears on Whatman® FTA® Elute Card (FTA Card) and detection of travellers' diarrhoea (TD)-associated pathogens by using a quantitative Polymerase Chain Reaction (PCR) assay [customized TaqMan® array card (TAC)] in a prospective, observational cohort of travellers. METHODS: Enrolled travellers documented symptoms on a travel diary and collected an FTA Card during a diarrhoeal episode, or at the end of travel if they remained asymptomatic. TAC testing was performed on FTA Cards from TD cases and 1:1 matched asymptomatic controls and 1:1 matched loose stool cases that did not meet TD criteria. Odds ratios were used to determine the association between detected pathogens and TD. RESULTS: Of 2456 travellers, 484 (19.7%) completed an illness diary and met TD criteria, and 257 (53.1%) collected an FTA Card during the TD episode. FTA Cards were stored for a median of 2 years at room temperature (IQR: 1-4 years) before extraction and testing. The overall TAC detection rate in TD cases was 58.8% (95% CI: 52.5-64.8). Enterotoxigenic Escherichia coli was the most common pathogen in TD cases (26.8%), and 3.5% of samples were positive for norovirus. The odds of detecting TD-associated pathogens in 231 matched cases and asymptomatic controls were 5.4 (95% CI: 3.6-8.1) and 2.0 (95% CI: 1.1-3.7) in 121 matched TD and loose stool cases (P < 0.05). Enteroaggregative E. coli was the most common pathogen detected in asymptomatic controls and loose stool cases. Detection of diarrhoeagenic E. coli, Shigella/enteroinvasive E. coli and Campylobacter spp. was significantly associated with TD. CONCLUSION: FTA Cards are a useful adjunct to traditional stool collection methods for evaluating the pathogen-specific epidemiology of TD in austere environments. Qualitative detection of pathogens was associated with TD. Measures to improve compliance and quality of FTA Card collection with decreased storage duration may further optimize detection.
BACKGROUND: We assessed the compliance with self-collection of stool smears on Whatman® FTA® Elute Card (FTA Card) and detection of travellers' diarrhoea (TD)-associated pathogens by using a quantitative Polymerase Chain Reaction (PCR) assay [customized TaqMan® array card (TAC)] in a prospective, observational cohort of travellers. METHODS: Enrolled travellers documented symptoms on a travel diary and collected an FTA Card during a diarrhoeal episode, or at the end of travel if they remained asymptomatic. TAC testing was performed on FTA Cards from TD cases and 1:1 matched asymptomatic controls and 1:1 matched loose stool cases that did not meet TD criteria. Odds ratios were used to determine the association between detected pathogens and TD. RESULTS: Of 2456 travellers, 484 (19.7%) completed an illness diary and met TD criteria, and 257 (53.1%) collected an FTA Card during the TD episode. FTA Cards were stored for a median of 2 years at room temperature (IQR: 1-4 years) before extraction and testing. The overall TAC detection rate in TD cases was 58.8% (95% CI: 52.5-64.8). Enterotoxigenic Escherichia coli was the most common pathogen in TD cases (26.8%), and 3.5% of samples were positive for norovirus. The odds of detecting TD-associated pathogens in 231 matched cases and asymptomatic controls were 5.4 (95% CI: 3.6-8.1) and 2.0 (95% CI: 1.1-3.7) in 121 matched TD and loose stool cases (P < 0.05). Enteroaggregative E. coli was the most common pathogen detected in asymptomatic controls and loose stool cases. Detection of diarrhoeagenic E. coli, Shigella/enteroinvasive E. coli and Campylobacter spp. was significantly associated with TD. CONCLUSION: FTA Cards are a useful adjunct to traditional stool collection methods for evaluating the pathogen-specific epidemiology of TD in austere environments. Qualitative detection of pathogens was associated with TD. Measures to improve compliance and quality of FTA Card collection with decreased storage duration may further optimize detection.
Authors: Zhi-Dong Jiang; Brett Lowe; M P Verenkar; David Ashley; Robert Steffen; Nadia Tornieporth; Frank von Sonnenburg; Peter Waiyaki; Herbert L DuPont Journal: J Infect Dis Date: 2002-01-22 Impact factor: 5.226
Authors: C Paschke; N Apelt; E Fleischmann; P Perona; C Walentiny; T Löscher; K-H Herbinger Journal: Clin Microbiol Infect Date: 2010-12-13 Impact factor: 8.067
Authors: Hagen Frickmann; Philipp Warnke; Claudia Frey; Salvatore Schmidt; Christian Janke; Kay Erkens; Ulrich Schotte; Thomas Köller; Winfried Maaßen; Andreas Podbielski; Alfred Binder; Rebecca Hinz; Benjamin Queyriaux; Dorothea Wiemer; Norbert Georg Schwarz; Ralf Matthias Hagen Journal: Biomed Res Int Date: 2015-10-11 Impact factor: 3.411
Authors: Jie Liu; Jean Gratz; Caroline Amour; Rosemary Nshama; Thomas Walongo; Athanasia Maro; Esto Mduma; James Platts-Mills; Nadia Boisen; James Nataro; Doris M Haverstick; Furqan Kabir; Paphavee Lertsethtakarn; Sasikorn Silapong; Pimmada Jeamwattanalert; Ladaporn Bodhidatta; Carl Mason; Sharmin Begum; Rashidul Haque; Ira Praharaj; Gagandeep Kang; Eric R Houpt Journal: PLoS One Date: 2016-06-23 Impact factor: 3.240
Authors: Amanda K Debes; Jerome Ateudjieu; Etienne Guenou; Etiene Guenou; Anna Lena Lopez; Mark Philip Bugayong; Pearl Joy Retiban; Marcelino Garrine; Inacio Mandomando; Shan Li; O Colin Stine; David A Sack Journal: PLoS Negl Trop Dis Date: 2016-01-06
Authors: Tahaniyat Lalani; Michele D Tisdale; Jie Liu; Indrani Mitra; Cliff Philip; Elizabeth Odundo; Faviola Reyes; Mark P Simons; Jamie A Fraser; Emma Hutley; Patrick Connor; Brett E Swierczewski; Eric Houpt; David R Tribble; Mark S Riddle Journal: PLoS One Date: 2018-08-30 Impact factor: 3.240